Flecainide acetate and Sandostatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Flecainide acetate (flecainide acetate) and Sandostatin (octreotide acetate). Common drug interactions include suffocation feeling among females and bundle branch block right among males.
The phase IV clinical study analyzes what interactions people have when they take Flecainide acetate and Sandostatin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Flecainide acetate?
Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.
What is Sandostatin?
Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 46,793 Sandostatin users. Check the latest studies of Sandostatin.
20 people who take Flecainide acetate and Sandostatin together, and have interactions are studied.

What are the common drug interactions of Flecainide Acetate and Sandostatin, by gender? *:
female:
- Suffocation feeling
- Vomiting
- Arthralgia (joint pain)
- Blood pressure systolic increased
- Cardiac failure
- Cough
- Dehydration (dryness resulting from the removal of water)
- Dyspnoea (difficult or laboured respiration)
- Injection site pain
- Pain
male:
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Carcinoid heart disease (heart valve disease)
- Pruritus (severe itching of the skin)
- Renal impairment (severely reduced kidney function)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Cardiac death
- Dry skin
- Flushing (the warm, red condition of human skin)
- Malignant neoplasm progression (cancer tumour came back)
- Mesenteric neoplasm (tumour of mesenteric artery)
What are the common drug interactions of Flecainide Acetate and Sandostatin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
60+:
- Arthralgia (joint pain)
- Blood pressure systolic increased
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Back pain
- Bladder disorder
- Blood glucose decreased
- Blood pressure increased
- Bone disorder
- Bone pain
- Change of bowel habit
What are the existing conditions these people have? *
- Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 13 people, 65.00%
- Sleep Disorder: 3 people, 15.00%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 15.00%
- Neuroendocrine Tumor: 1 person, 5.00%
- Metastatic Carcinoid Tumor: 1 person, 5.00%
- Infusion Site Infection: 1 person, 5.00%
- Blood Calcium Decreased: 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Flecainide acetate and Sandostatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Flecainide acetate (7,176 reports)
- Sandostatin (46,793 reports)
Browse all drug interactions of Flecainide acetate and Sandostatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flecainide acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sandostatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flecainide acetate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sandostatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on flecainide acetate and octreotide acetate (the active ingredients of Flecainide acetate and Sandostatin, respectively), and Flecainide acetate and Sandostatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Antara and Fluconazole - 5 seconds ago
- Paroxetine vs. Niravam, side effect and effectiveness comparison - 14 seconds ago
- Could Reglan cause Cognitive Disorder? - 17 seconds ago
- Could Lopid cause Lung Disorder? - 31 seconds ago
- Meridia vs. Fastin, side effect and effectiveness comparison - 49 seconds ago
- Could Lamictal cause Parkinson'S Disease? - 50 seconds ago
- Could Spiriva cause Immunoglobulins Decreased? - 57 seconds ago
- Drug interactions of L-Lysine and Folate - a minute ago
- Cardiac Failure Chronic and Mobility Decreased - a minute ago
- Could Mirtazapine cause Overdose? - a minute ago